Pooled Analysis of Studies Evaluating Fosnetupitant and Risk Factors for Cisplatin-Induced Nausea and Vomiting During the Extended Overall Phase.

Naoki InuiYukihiro ToiYasuto YoneshimaMasahiro MoriseAkito HataKaoru KubotaToshiaki SaekiTomohide Tamura

Published in: Advances in therapy (2023)

This analysis revealed that fosnetupitant could have long-acting antiemetic potency (> 120 h) and indicated the importance of antiemetic therapy at 0-120 h for CINV up to 168 h after chemotherapy.

Keyphrases

chemotherapy induced
single cell
locally advanced
radiation therapy
bone marrow